Delta 9 Cannabis provides guidance for Q2 financials with what looks like a heavy rise in revenue
Delta 9 Cannabis (TSE: DN – OTCQX: DLTNF) CEO John Arbuthnot joined Steve Darling from Proactive to share guidance as the company releases Q2 and half-year financials. The guidance is calling for a rise in revenue with the three-month period ending June 30, 2021, to be between 15.5 million and 17.25 million compared with 13.23 million for Q1 of 2021. The 6 month period will be between $28.75 million and $30.5 million, compared to 24.76 million for the same period last year. Arbuthnot telling Proactive what is leading to this rise and he also shared with Proactive, the company is getting involved in the vaccination program in Manitoba by offering Joint for Jabs.
Watch the interview below, or by following this link.